资讯

生物谷4 年
Cell：中国科学家开发一种SARS-CoV-2灭活疫苗，BBIBP-CorV，动物实验显示 ...
在这项研究中，研究人员报道了一种灭活的SARS-CoV-2候选疫苗(BBIBP-CorV)的实验性生产。在动物试验中，研究人员发现该疫苗在小鼠、大鼠、豚鼠、兔子 ...
生物谷2 年
柳叶刀子刊：两剂灭活疫苗后的蛋白亚基疫苗加强剂，可对新冠病毒 ...
研究思路及结果展示 该研究选择灭活疫苗BBIBP-CorV（国药）和基于受体结合域（RBD）的串联重复二聚体蛋白亚基疫苗ZF2001。探究了两剂量接种方案和 ...
腾讯网4 年
WHO首次公开国药疫苗评估报告：国药疫苗保护效力78.1％
上一日接种约469万剂次。 5月3日，世界卫生组织发布了对中国国药集团北京生物疫苗BBIBP-CorV、科兴CoronaVac COVID-19疫苗的评估报告，并很可能进一步 ...
生物通4 年
中国灭活SARS-CoV-2疫苗的人体试验结果在《柳叶刀传染病》发表
中国于2020年4月29日至7月30日进行了SARS-CoV-2灭活疫苗候选品（BBIBP-CorV）的1/2期随机对照试验，共有600多名健康志愿者参与 ...
腾讯网4 年
NEJM：国药和科兴疫苗对突变株中和效力数据发布，再次证实病毒变异 ...
在国药bbibp-corv疫苗接种者血清样本中，尽管针对变异株的中和抗体gmt与针对野生型病毒的gmt无显著差异，但有20份血清样本对b.1.351完全或部分丧失 ...
scmp.com3 年
Sinopharm protein-based booster stronger against Omicron than earlier shot
The study which was published on Tuesday and had not been peer reviewed, came amid concerns over the effectiveness of Sinopharm’s BBIBP-CorV shot, one of the two leading Covid-19 vaccines ...
Yahoo Finance6 年
CORV: Topline Growth Accelerating
Correvio Pharma Corp. (CORV) issued a press release reporting third quarter 2018 results on November 6, 2018 posting revenues of $7.0 million, a 16% increase over the prior year. Loss per share ...
Yahoo Finance5 年
Correvio Pharma Corp. (TSE:CORV) Is Expected To Breakeven
Correvio Pharma Corp.'s (TSE:CORV): Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. With the latest financial year loss of -US$16.6m and a ...
The New York Times4 年
How the Sinopharm Vaccine Works
In early 2020, the Beijing Institute of Biological Products created an inactivated coronavirus vaccine called BBIBP-CorV. Clinical trials run by the state-owned company Sinopharm showed that it ...
BioWorld4 年
Items Tagged with 'BBIBP-CorV'
Seychelles has seen rising numbers of COVID-19 cases despite 61% of its population being fully vaccinated as of May 8, calling into question the effectiveness of the COVID-19 vaccines used by the ...